Paper23722425
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.
Weiskopf K and 10 others. Science, 2013. Cited by 424 papers, by iCite.
Cite this record
ConductScience Library. Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies. Papers, record 23722425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23722425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| Antigens, Differentiation | Major topic |
| CD47 Antigen | Major topic |
| Neoplasms | Major topic |
| Receptors, Immunologic | Major topic |
| Animals | |
| Antibodies, Monoclonal, Murine-Derived | |
| Cell Line, Tumor | |
| Directed Molecular Evolution | |
| Humans | |
| Immunotherapy | |
| Macrophage Activation | |
| Mice | |
| Phagocytosis | |
| Rituximab |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 GM007365 | NIGMS NIH HHS | United States | T32GM007365 | PubMed and NIH | NIH RePORTER |
| F30CA168059 | NCI NIH HHS | United States | F30CA168059 | PubMed and NIH | NIH RePORTER |
| F30DK094541 | NIDDK NIH HHS | United States | F30DK094541 | PubMed and NIH | NIH RePORTER |
| F30 DK094541 | NIDDK NIH HHS | United States | F30DK094541 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| R01 CA086017 | NCI NIH HHS | United States | R01CA086017 | PubMed and NIH | NIH RePORTER |
| GM07365 | NIGMS NIH HHS | United States | T32GM007365 | PubMed and NIH | NIH RePORTER |
| CA139490 | NCI NIH HHS | United States | P01CA139490 | PubMed and NIH | NIH RePORTER |
| P01 CA139490 | NCI NIH HHS | United States | P01CA139490 | PubMed and NIH | NIH RePORTER |
| F30 CA168059 | NCI NIH HHS | United States | F30CA168059 | PubMed and NIH | NIH RePORTER |
| R01 CA177684 | NCI NIH HHS | United States | R01CA177684 | PubMed and NIH | NIH RePORTER |
| R01 CA112270 | NCI NIH HHS | United States | R01CA112270 | PubMed and NIH | NIH RePORTER |
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 23743478 | Tumour immunology: cracking the combination. | https://conductscience.org/library/papers/23743478 | PubMed |
| Comment in | 23812266 | Anticancer drugs: Cracking the combination. | https://conductscience.org/library/papers/23812266 | PubMed |
| Comment in | 23828933 | Immunology. Making macrophages eat cancer. | https://conductscience.org/library/papers/23828933 | PubMed |
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17369261 | The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17369261 | PubMed |
| 2 | 10572074 | Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. | Blood | 1999 | https://conductscience.org/library/papers/10572074 | PubMed |
| 3 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 4 | 1717984 | Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1717984 | PubMed |
| 5 | 22451919 | Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22451919 | PubMed |
| 6 | 20813259 | Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. | Cell | 2010 | https://conductscience.org/library/papers/20813259 | PubMed |
| 7 | 16290005 | Single step protocol to purify recombinant proteins with low endotoxin contents. | Protein Expr Purif | 2006 | https://conductscience.org/library/papers/16290005 | PubMed |
| 8 | 23293079 | Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. | Blood | 2013 | https://conductscience.org/library/papers/23293079 | PubMed |
| 9 | 20383002 | Features and development of Coot. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20383002 | PubMed |
| 10 | 19339720 | Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19339720 | PubMed |
| 11 | 20124702 | PHENIX: a comprehensive Python-based system for macromolecular structure solution. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20124702 | PubMed |
| 12 | 19632179 | CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. | Cell | 2009 | https://conductscience.org/library/papers/19632179 | PubMed |
| 13 | 22451913 | The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22451913 | PubMed |
| 14 | 19632178 | CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. | Cell | 2009 | https://conductscience.org/library/papers/19632178 | PubMed |
| 15 | 8596936 | Enhancement of antitumor immunity by CTLA-4 blockade. | Science | 1996 | https://conductscience.org/library/papers/8596936 | PubMed |
| 16 | 18657508 | Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. | Mol Cell | 2008 | https://conductscience.org/library/papers/18657508 | PubMed |
| 17 | 21436454 | CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. | Science | 2011 | https://conductscience.org/library/papers/21436454 | PubMed |
| 18 | 10856220 | Role of CD47 as a marker of self on red blood cells. | Science | 2000 | https://conductscience.org/library/papers/10856220 | PubMed |
| 19 | 17982459 | Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. | Nat Immunol | 2007 | https://conductscience.org/library/papers/17982459 | PubMed |
| 20 | 17154393 | Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. | Cancer | 2007 | https://conductscience.org/library/papers/17154393 | PubMed |
Cited by314
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 424 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42946800 | Macrophage biology and immunoregulation in health and disease. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42946800 | PubMed |
| 42911425 | The pivotal role of macrophages in tumorigenesis and pioneering cancer immunotherapy across pre-clinical and clinical frontiers. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42911425 | PubMed |
| 42686375 | GTPase RAB31 supports ANXA1-driven macrophage education through clathrin-mediated endocytosis to suppress antitumor immunity. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42686375 | PubMed |
| 42608405 | High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma. | Nat Commun | 2026 | https://conductscience.org/library/papers/42608405 | PubMed |
| 42439665 | Diffuse Large B-Cell Lymphoma: From Molecular Stratification to Precision Immunotherapy. | Cells | 2026 | https://conductscience.org/library/papers/42439665 | PubMed |
| 42384015 | Hyperlactataemia in lymphoma-associated haemophagocytic lymphohistiocytosis: Linked to monocytic glycolysis and adverse prognosis. | Br J Haematol | 2026 | https://conductscience.org/library/papers/42384015 | PubMed |
| 42282282 | Macrophage-Targeted Single Walled Carbon Nanotubes Stimulate Phagocytosis via pH-dependent Drug Release. | Nano Res | 2021 | https://conductscience.org/library/papers/42282282 | PubMed |
| 42251359 | Engineering a PD-L1-sensing synthetic receptor for programmable macrophage response. | J Biol Eng | 2026 | https://conductscience.org/library/papers/42251359 | PubMed |
| 42183275 | Neutrophil efferocytosis in chronic inflammatory gastrointestinal diseases: mechanistic insights and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183275 | PubMed |
| 41822520 | The SIRP family: from structural diversity and signaling mechanisms to implications in immune-related disease targeted therapeutics. | Front Immunol | 2026 | https://conductscience.org/library/papers/41822520 | PubMed |
| 41811295 | Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma. | Expert Opin Investig Drugs | 2026 | https://conductscience.org/library/papers/41811295 | PubMed |
| 41601654 | FACS-based genome-wide CRISPR screening platform identifies modulators of CD47. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601654 | PubMed |
| 41556358 | PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41556358 | PubMed |
| 41514569 | Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41514569 | PubMed |
| 41497624 | Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug design. | bioRxiv | 2025 | https://conductscience.org/library/papers/41497624 | PubMed |
| 41444487 | Intraperitoneal programming of tailored CAR macrophages via mRNA lipid nanoparticle to boost cancer immunotherapy. | Nat Commun | 2025 | https://conductscience.org/library/papers/41444487 | PubMed |
| 41425717 | Research Progress of Drug Delivery Systems Consisting of Hydrogels Loaded with Extracellular Vesicles in Tumor Therapy. | Oncol Res | 2025 | https://conductscience.org/library/papers/41425717 | PubMed |
| 41423264 | TIPE2 deficiency enhances macrophage phagocytosis of tumor cells. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/41423264 | PubMed |
| 41360986 | Targeting phagocytosis checkpoints for cancer immunotherapy. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41360986 | PubMed |
| 41290673 | Bioorthogonal optimized virus immuno-nanomedicine (BOVIN). | Nat Commun | 2025 | https://conductscience.org/library/papers/41290673 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGA2 | 100188771 | PubTator's text mining | https://conductscience.org/library/genes/100188771 | NCBI Gene |
| CD47 | 961 | PubTator's text mining | https://conductscience.org/library/genes/961 | NCBI Gene |
| CD52 | 1043 | PubTator's text mining | https://conductscience.org/library/genes/1043 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| SIRPA | 140885 | PubTator's text mining | https://conductscience.org/library/genes/140885 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| PDB | 4KJY |
Source PDB
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23722425
GET https://conductscience.org/api/papers/v1/23722425/references?page=2